MedTrace Logo

A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial

NCT01645202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 241

Last updated 2019-07-26

No results posted yet for this study

Summary

A randomized controlled multicenter study comparing the acute hemodynamic performance of the Edwards Sapien XT and the Medtronic CoreValve transcatheter heart valves in high risk patients with severe symptomatic aortic stenosis.

Conditions

  • Aortic Stenosis

Interventions

PROCEDURE

Transcatheter Aortic Valve Implantation (TAVI)

Comparison of different types of valves

Sponsors & Collaborators

  • Segeberger Kliniken GmbH

    lead OTHER

Principal Investigators

  • Mohamed Abdel-Wahab, MD · Herzzentrum, Segeberger Kliniken, Bad Segeberg, Germany

  • Gert Richardt, MD · Herzzentrum, Segeberger Kliniken, Bad Segeberg, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-12-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645202 on ClinicalTrials.gov